[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
January 6, 1962

Council on Drugs

JAMA. 1962;179(1):55-58. doi:10.1001/jama.1962.03050010057009

Monographs on which these digests are based will be compiled and published annually in New and Nonofficial Drugs; interim copies of the complete monographs may be obtained on request from the Secretary, Council on Drugs, American Medical Association, Chicago.

Scientific data were supplied to the Council by Bristol Laboratories, Inc. (potassium phenethicillin); Lederle Laboratories (methazolamide, smallpox vaccine [chick embryo]); The S. E. Massengill Co. (glaucarubin); Mead Johnson & Co. (cyclophosphamide); Merck Sharp & Dohme (phenazocine hydrobromide); Parke Davis & Co. (pyrvinium pamoate); J. B. Roerig & Co. (clemizole hydrochloride, potassium phenethicillin); G. D. Searle & Co. (spironolactone); Smith Kline & French Laboratories (phenazocine hydrobromide); Warner-Chilcott Laboratories (phenelzine sulfate); The Warren-Teed Products Co. (dexpanthenol); and Wyeth Laboratories (potassium phenethicillin).

First Page Preview View Large
First page PDF preview
First page PDF preview
×